Search Results - "Mansour, Edward G."

Long-Term Follow-Up of a Phase II Trial of High-Dose Radiation With Concurrent 5-Fluorouracil and Cisplatin in Patients With Anal Cancer (ECOG E4292) by Chakravarthy, A. Bapsi, M.D, Catalano, Paul J., Sc.D, Martenson, James. A., M.D, Mondschein, Joshua K., M.D, Wagner, Henry, M.D, Mansour, Edward G., M.D, Talamonti, Mark S., M.D, Benson, Al Bowen, M.D

“…Purpose Although chemoradiation using 5-fluorouracil (5-FU) and mitomycin-C (MMC) is the standard of care in the treatment of anal cancer, many patients are…”
Get full text

The national cancer data base report on gastric carcinoma by Hundahl, Scott A., Menck, Herman R., Mansour, Edward G., Winchester, David P.

“…BACKGROUND The National Cancer Data Base (NCDB) represents a national electronic registry system now encompassing almost 60% of incident cancers in the United…”
Get full text

A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging by Averbook, Bruce J., Fu, Pingfu, Rao, J.Sunil, Mansour, Edward G.

“…Background. Traditional statistical analysis of 2 surgeons' experiences with resectable malignant melanoma during a 30-year period (November 1970-July 2000)…”
Get full text

Comparison of 5‐fluorouracil alone, 5‐fluorouracil with levamisole, and 5‐fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra‐abdominal metastasis after undergoing resection for colorectal carcinoma by Witte, Robert S., Cnaan, Avital, Mansour, Edward G., Barylak, Edward, Harris, Jules E., Schutt, Allan J.

“…BACKGROUND The authors conducted a randomized Phase III trial of three treatment regimens for patients with residual, nonmeasurable, intra‐abdominal metastatic…”
Get full text

Barriers to clinical trials. Part III: Knowledge and attitudes of health care providers by Mansour, E G

“…The role of clinical trials is becoming extremely important for our understanding of the effects of different therapeutic modalities of cancer treatment and…”
Get more information

Prognostic factors in early breast carcinoma by Mansour, E G, Ravdin, P M, Dressler, L

“…Several investigators, the SEER data, and the ECOG/Intergroup study have shown that patients with small tumors (< 0.5 cm) have a recurrence rate of less than…”
Get more information

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma by Allred, D C, Clark, G M, Tandon, A K, Molina, R, Tormey, D C, Osborne, C K, Gilchrist, K W, Mansour, E G, Abeloff, M, Eudey, L

“…Amplification and/or overexpression of the HER-2/neu oncogene have been shown to correlate with poor clinical outcome in patients with axillary node-positive…”
Get more information

Survival advantage of adjuvant chemotherapy in high-risk node-negative breast cancer: ten-year analysis--an intergroup study by Mansour, E G, Gray, R, Shatila, A H, Tormey, D C, Cooper, M R, Osborne, C K, Falkson, G

“…Preliminary analysis showed that adjuvant chemotherapy is effective in improving disease-free survival (DFS) among high-risk breast cancer patients. This…”
Get more information

Initial results of a phase II trial of high dose radiation therapy, 5-fluorouracil, and cisplatin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group study by Martenson, J A, Lipsitz, S R, Wagner, Jr, H, Kaplan, E H, Otteman, L A, Schuchter, L M, Mansour, E G, Talamonti, M S, Benson, 3rd, A B

“…A prospective clinical trial was performed to assess the response and toxicity associated with the use of high dose radiation therapy, 5-fluorouracil, and…”
Get more information

Comparative analysis of minimally invasive microductectomy versus major duct excision in patients with pathologic nipple discharge. Discussion by SHARMA, Ranjna, DIETZ, Jill, WRIGHT, Heather, CROWE, Joseph, DINUNZIO, Annette, WOLETZ, Joanne, KIM, Julian, SAUTER, Edward R, SCOTT-CONNER, Carol E. H, MANSOUR, Edward G

Get full text

Squamous cell carcinoma of the breast: a clinical approach by Stevenson, J T, Graham, D J, Khiyami, A, Mansour, E G

“…Squamous cell carcinoma (SCC) of the breast is rare. It remains unclear whether a "pure" form of SCC exists or if all known cases actually represent an extreme…”
Get full text

A long-term analysis of 620 patients with malignant melanoma at a major referral center by Averbook, Bruce J., Russo, Leo J., Mansour, Edward G.

“…Background: A univariate and multivariate statistical analysis of a single surgeon's experience with resectable malignant melanoma during 26 years (November…”
Get full text

Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen by Gale, K E, Andersen, J W, Tormey, D C, Mansour, E G, Davis, T E, Horton, J, Wolter, J M, Smith, T J, Cummings, F J

“…Tamoxifen and aminoglutethimide are two hormone therapies reported to be effective palliative approaches for patients with metastatic breast cancer. The…”
Get more information

Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients by Clark, G M, Mathieu, M C, Owens, M A, Dressler, L G, Eudey, L, Tormey, D C, Osborne, C K, Gilchrist, K W, Mansour, E G, Abeloff, M D

“…Formalin-fixed, paraffin-embedded tissues from axillary node-negative breast cancer patients were analyzed by flow cytometry to determine the prognostic…”
Get more information

A long-term analysis of 1018 patients with melanoma by classic Cox regression and tree-structured survival analysis at a major referral center: Implications on the future of cancer staging. Discussion by AVERBOOK, Bruce J, PINGFU FU, SUNIL RAO, J, MANSOUR, Edward G, POLK, Hiram C, MALAFA, Mokenge

Get full text

Recombinant Granulocyte-Macrophage Colony-Stimulating Factor After Autologous Bone Marrow Transplantation for Relapsed Non-Hodgkin's Lymphoma: Blood and Bone Marrow Progenitor Growth Studies. A Phase II Eastern Cooperative Oncology Group Trial by Lazarus, Hillard M., Andersen, Janet, Chen, Michael G., Variakojis, Diane, Mansour, Edward G., Oette, Dagmar, Arce, Cheryl A., Oken, Martin M., Gerson, Stanton L.

“…Sixteen patients with relapsed non-Hodgkin's lymphoma underwent autologous bone marrow transplantation and infusion of recombinant human granulocyte-macrophage…”
Get full text

The value of prognostic factors in selecting node-negative breast cancer patients for adjuvant therapy by Mansour, E G

Get more information

The role of pre-resectional laser recanalization for obstructing carcinomas of the colon and rectum by Eckhauser, M L, Imbembo, A L, Mansour, E G

“…The Nd:YAG laser has proved its efficacy for recanalizing obstructing lesions throughout the gastrointestinal tract. In a preliminary report using the Nd:YAG…”
Get more information

Tissue and plasma carcinoembryonic antigen in early breast cancer. A prognostic factor by Mansour, E G, Hastert, M, Park, C H, Koehler, K A, Petrelli, M

“…A prospective study of plasma and tissue carcinoembryonic antigen (P-CEA and T-CEA) levels in 63 patients with early (Stage I and II) breast cancer was…”
Get more information

Phase II trial of etoposide, doxorubicin, and cisplatin combination in advanced measurable gastric cancer. An Eastern Cooperative Oncology Group study by Clark, J L, Küçük, O, Neuberg, D S, Benson, 3rd, A B, Taylor, 4th, S G, Pandya, K J, Mansour, E G, Douglass, Jr, H O, Haller, D G

“…A phase II study was performed to determine the efficacy and toxicity of the etoposide, doxorubicin, cisplatin (EAP) regimen in the treatment of patients with…”
Get more information